↓ Skip to main content

Estimated Incidence of Antimicrobial Drug–Resistant Nontyphoidal Salmonella Infections, United States, 2004–2012 - Volume 23, Number 1—January 2017 - Emerging Infectious Diseases journal - CDC

Overview of attention for article published in Emerging Infectious Diseases, January 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
5 news outlets
twitter
19 X users
facebook
2 Facebook pages

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
92 Mendeley
Title
Estimated Incidence of Antimicrobial Drug–Resistant Nontyphoidal Salmonella Infections, United States, 2004–2012 - Volume 23, Number 1—January 2017 - Emerging Infectious Diseases journal - CDC
Published in
Emerging Infectious Diseases, January 2016
DOI 10.3201/eid2301.160771
Pubmed ID
Authors

Felicita Medalla, Weidong Gu, Barbara E. Mahon, Michael Judd, Jason Folster, Patricia M. Griffin, Robert M. Hoekstra

Abstract

Salmonella infections are a major cause of illness in the United States. The antimicrobial agents used to treat severe infections include ceftriaxone, ciprofloxacin, and ampicillin. Antimicrobial drug resistance has been associated with adverse clinical outcomes. To estimate the incidence of resistant culture-confirmed nontyphoidal Salmonella infections, we used Bayesian hierarchical models of 2004-2012 data from the Centers for Disease Control and Prevention National Antimicrobial Resistance Monitoring System and Laboratory-based Enteric Disease Surveillance. We based 3 mutually exclusive resistance categories on susceptibility testing: ceftriaxone and ampicillin resistant, ciprofloxacin nonsusceptible but ceftriaxone susceptible, and ampicillin resistant but ceftriaxone and ciprofloxacin susceptible. We estimated the overall incidence of resistant infections as 1.07/100,000 person-years for ampicillin-only resistance, 0.51/100,000 person-years for ceftriaxone and ampicillin resistance, and 0.35/100,000 person-years for ciprofloxacin nonsusceptibility, or ≈6,200 resistant culture-confirmed infections annually. These national estimates help define the magnitude of the resistance problem so that control measures can be appropriately targeted.

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mozambique 1 1%
Unknown 91 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 16%
Student > Ph. D. Student 12 13%
Student > Doctoral Student 8 9%
Student > Bachelor 8 9%
Researcher 7 8%
Other 8 9%
Unknown 34 37%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 13%
Veterinary Science and Veterinary Medicine 11 12%
Biochemistry, Genetics and Molecular Biology 9 10%
Immunology and Microbiology 8 9%
Medicine and Dentistry 4 4%
Other 12 13%
Unknown 36 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 50. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2022.
All research outputs
#795,911
of 24,495,755 outputs
Outputs from Emerging Infectious Diseases
#951
of 9,479 outputs
Outputs of similar age
#14,256
of 403,453 outputs
Outputs of similar age from Emerging Infectious Diseases
#12
of 129 outputs
Altmetric has tracked 24,495,755 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,479 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.5. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 403,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 129 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.